<VariationArchive RecordType="classified" VariationID="2429242" VariationName="NC_000007.13:g.(146536997_146740998)_(146741147_146805238)del" VariationType="Deletion" Accession="VCV002429242" Version="5" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-11-11" DateCreated="2023-02-13" MostRecentSubmission="2023-11-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2402675" VariationID="2429242">
      <GeneList>
        <Gene Symbol="CNTNAP2" FullName="contactin associated protein 2" GeneID="26047" HGNC_ID="HGNC:13830" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7q35-36.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="146116801" stop="148420998" display_start="146116801" display_stop="148420998" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NT_187564.1" start="2405" stop="204593" display_start="2405" display_stop="204593" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="145813452" stop="148118089" display_start="145813452" display_stop="148118089" Strand="+" />
          </Location>
          <OMIM>604569</OMIM>
          <Haploinsufficiency last_evaluated="2019-10-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CNTNAP2">Little evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2019-10-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CNTNAP2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000007.13:g.(146536997_146740998)_(146741147_146805238)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>7q35</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" outerStart="146536997" innerStart="146740998" innerStop="146741147" outerStop="146805238" display_start="146536997" display_stop="146805238" variantLength="268242" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.(146536997_146740998)_(146741147_146805238)del" Assembly="GRCh37">
            <Expression>NC_000007.13:g.(146536997_146740998)_(146741147_146805238)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000007.13:g.(146536997_146740998)_(146741147_146805238)del AND Cortical dysplasia-focal epilepsy syndrome" Accession="RCV003123481" Version="3">
        <ClassifiedConditionList TraitSetID="1535">
          <ClassifiedCondition DB="MedGen" ID="C2750246">Cortical dysplasia-focal epilepsy syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-01-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-01-16" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-13" MostRecentSubmission="2023-11-11">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">28726809</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">34778490</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">34926809</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1535" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4859" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Cortical dysplasia-focal epilepsy syndrome</ElementValue>
                <XRef ID="Cortical+dysplasia-focal+epilepsy+syndrome/8098" DB="Genetic Alliance" />
                <XRef ID="MONDO:0012400" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pitt-Hopkins-like syndrome 1</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PTHSL1</ElementValue>
                <XRef Type="MIM" ID="610042" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16997" />
                <XRef ID="16997" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="163681" DB="Orphanet" />
              <XRef ID="221150" DB="Orphanet" />
              <XRef ID="C2750246" DB="MedGen" />
              <XRef ID="MONDO:0012400" DB="MONDO" />
              <XRef Type="MIM" ID="610042" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7081696" SubmissionDate="2023-02-06" DateLastUpdated="2023-11-11" DateCreated="2023-02-13">
        <ClinVarSubmissionID localKey="NC_000007.13:g.(146536997_146740998)_(146741147_146805238)del|MedGen:C2750246" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003801077" DateUpdated="2023-11-11" DateCreated="2023-02-13" Type="SCV" Version="2" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-01-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">28726809</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">34926809</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">34778490</ID>
          </Citation>
          <Comment>Variant summary: The variant identified by MLPA or other technology involves the deletion of exon 4 in the CNTNAP2 gene. A presumed nomenclature of c.(402+1_403-1)_(550+1_551-1)del has been designated for the purposes of this classification. Although exact breakpoints of this deletion are not known, it is expected to result in a frameshift in the CNTNAP2 gene, a known mechanism of disease. The variant was absent in 21274 control chromosomes in the gnomAD database (structural variants data set). Exon 4 deletion has been reported in the literature in individuals affected Pitt Hopkins-like syndrome 1 (Mittal_2021), epilepsy (McKnight_2021) and classic cortical dysplasia-focal epilepsy syndrome (Strauss_2018). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CNTNAP2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.(146536997_146740998)_(146741147_146805238)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2750246" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12766635</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7081696" TraitType="Disease" MappingType="XRef" MappingValue="C2750246" MappingRef="MedGen">
        <MedGen CUI="C2750246" Name="Cortical dysplasia-focal epilepsy syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

